Founded in 2020, Jameel Health is part of Abdul Latif Jameel. In January 2024, it acquired a majority stake in Genpharm. In June 2024, Jameel Health partnered with LPIXEL to distribute EIRL, an AI medical imaging diagnostic support technology, across selected MENAT and Global South markets. Bouchenaki was previously the executive director for Africa at Gilead Sciences and has held other roles at GSK and Bristol Myers Squibb.